Original Research
Published on 21 Sep 2023
Third-line treatment options in metastatic pancreatic cancer patients: a real-world study
Frontiers in Oncology
doi 10.3389/fonc.2023.1251258
- 261 views
Type at least 3 characters
661 articles
Articles
Original Research
Accepted on 20 Sep 2023
Discovery of a Haptoglobin Glycopeptides Biomarker Panel for Early Diagnosis of Hepatocellular Carcinoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1213898
Case Report
Accepted on 18 Sep 2023
Surgery after Combination Therapy with a Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody in Sarcomatoid Hepatocellular Carcinoma: Case Report and Literature Review
Frontiers in Oncology
doi 10.3389/fonc.2023.1212013
Systematic Review
Accepted on 18 Sep 2023
Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
Frontiers in Oncology
doi 10.3389/fonc.2023.1265240
Review
Published on 15 Sep 2023
Utility of interventional endoscopic ultrasound in pancreatic cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1252824
- 246 views
Original Research
Accepted on 11 Sep 2023
Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index (SII) and albumin-bilirubin (ALBI): A multicenter study
Frontiers in Oncology
doi 10.3389/fonc.2023.1239375
Case Report
Accepted on 11 Sep 2023
Case Report: A Complete Pathologic Response in Pancreatic Cancer with Squamous Cell Differentiation
Frontiers in Oncology
doi 10.3389/fonc.2023.1240405
Correction
Published on 11 Sep 2023
Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1282120
- 221 views
Original Research
Accepted on 07 Sep 2023
From Imaging to Clinical Outcome: Dual-Region CT Radiomics Predicting FOXM1 Expression and Prognosis in Hepatocellular Carcinoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1278467
Original Research
Published on 06 Sep 2023
Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study
Frontiers in Oncology
doi 10.3389/fonc.2023.1251873
- 537 views
Review
Published on 05 Sep 2023
Biliary drainage in malignant biliary obstruction: an umbrella review of randomized controlled trials
Frontiers in Oncology
doi 10.3389/fonc.2023.1235490
- 461 views
Original Research
Published on 01 Sep 2023
Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
Frontiers in Oncology
doi 10.3389/fonc.2023.1206565
- 671 views
Correction
Published on 31 Aug 2023
Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study
Frontiers in Oncology
doi 10.3389/fonc.2023.1278295
- 367 views
Correction
Published on 31 Aug 2023
Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1253552
- 620 views
Perspective
Published on 30 Aug 2023
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
Frontiers in Oncology
doi 10.3389/fonc.2023.1225154
- 672 views
Original Research
Published on 29 Aug 2023
Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1227036
- 709 views